Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0EV0H
|
|||
Drug Name |
PMID26911565-peptide-P9
|
|||
Synonyms |
PMID26911565-P9
Click to Show/Hide
|
|||
Drug Type |
Protein/peptide drug
|
|||
Indication | Middle East Respiratory Syndrome (MERS) [ICD-11: 1D64] | Preclinical | [1] | |
Severe acute respiratory syndrome (SARS) [ICD-11: 1D65] | Preclinical | [1] | ||
Therapeutic Class |
Antiviral Agents
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | MERS-CoV spike glycoprotein (S) | Target Info | Inhibitor | [1] |
SARS-CoV spike glycoprotein (S) | Target Info | Inhibitor | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | A novel peptide with potent and broad-spectrum antiviral activities against multiple respiratory viruses. Sci Rep. 2016 Feb 25;6:22008. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.